These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32711178)

  • 1. Treatment and Outcomes of Early Stage Breast Cancer in Patients with Hepatic Dysfunction.
    Olimpiadi YB; Brownson KE; Kahn JA; Kim B; Han H; Khemichian S; Fong TL; Kang I; Terando A; Lang JE
    J Surg Res; 2020 Dec; 256():212-219. PubMed ID: 32711178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.
    Suman A; Barnes DS; Zein NN; Levinthal GN; Connor JT; Carey WD
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):719-23. PubMed ID: 15290666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
    Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM
    Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.
    Ishigami M; Honda T; Okumura A; Ishikawa T; Kobayashi M; Katano Y; Fujimoto Y; Kiuchi T; Goto H
    J Gastroenterol; 2008; 43(5):363-8. PubMed ID: 18592154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased complication rates after hip and knee arthroplasty in patients with cirrhosis of the liver.
    Tiberi JV; Hansen V; El-Abbadi N; Bedair H
    Clin Orthop Relat Res; 2014 Sep; 472(9):2774-8. PubMed ID: 24993141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.
    Wedd J; Bambha KM; Stotts M; Laskey H; Colmenero J; Gralla J; Biggins SW
    Liver Transpl; 2014 Oct; 20(10):1193-201. PubMed ID: 24916539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.
    Conejo I; Guardascione MA; Tandon P; Cachero A; Castellote J; Abraldes JG; Amitrano L; Genescà J; Augustin S
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):132-139.e8. PubMed ID: 28501536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis.
    Hoteit MA; Ghazale AH; Bain AJ; Rosenberg ES; Easley KA; Anania FA; Rutherford RE
    World J Gastroenterol; 2008 Mar; 14(11):1774-80. PubMed ID: 18350609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
    Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
    Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.
    Bohra A; Worland T; Hui S; Terbah R; Farrell A; Robertson M
    World J Gastroenterol; 2020 May; 26(18):2221-2231. PubMed ID: 32476788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
    Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
    ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.